Balance Sheet Data
Ascendis Pharma A/S (ASND)
$88.79
+0.07 (+0.08%)
Year A/P | 2017 Actual | 2018 Actual | 2019 Actual | 2020 Actual | 2021 Actual | 2022 Projected | 2023 Projected | 2024 Projected | 2025 Projected | 2026 Projected |
| Total Cash | 195.35 | 277.86 | 598.11 | 718.80 | 682.06 | 1,488.11 | 3,652.66 | 8,965.68 | 22,006.83 | 54,017.14 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Cash (%) | ||||||||||
| Account Receivables | 2.38 | 2.63 | 5.41 | 7.34 | 23.19 | 23.84 | 58.52 | 143.63 | 352.55 | 865.35 |
| Account Receivables (%) | ||||||||||
| Inventories | - | - | - | - | 75.41 | 185.09 | 454.31 | 1,115.12 | 2,737.14 | 6,718.47 |
| Inventories (%) | ||||||||||
| Accounts Payable | 23.77 | 19.74 | 27.77 | 21.90 | 59.42 | 115.56 | 283.65 | 696.23 | 1,708.95 | 4,194.71 |
| Accounts Payable (%) | ||||||||||
| Capital Expenditure | -0.94 | -2.65 | -5.16 | -21.55 | -24.23 | -28.51 | -69.98 | -171.76 | -421.60 | -1,034.85 |
| Capital Expenditure (%) |
To support growth, companies need to keep investing in capital items – including property, plants and equipment.
To calculate this net investment,we take capital expenditure (found in the company’s statement of cash flows)
and subtract non-cash depreciation (found on the income statement).
Working capital refers to the cash a company needs for day-to-day operations.
The faster a company expands, the more cash it will need.
To calculate working capital, we take current assets and subtract current liabilities.
You can find both of these on a company’s balance sheet, which is published in its quarterly and annual financial statements.